These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27894076)

  • 1. Co-expression of Piwil2/Piwil4 in nucleus indicates poor prognosis of hepatocellular carcinoma.
    Zeng G; Zhang D; Liu X; Kang Q; Fu Y; Tang B; Guo W; Zhang Y; Wei G; He D
    Oncotarget; 2017 Jan; 8(3):4607-4617. PubMed ID: 27894076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients.
    Chen YL; Lin PY; Ming YZ; Huang WC; Chen RF; Chen PM; Chu PY
    BMC Cancer; 2017 Jul; 17(1):474. PubMed ID: 28687090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HEPPAR1 and PIWIL2 as Panel Markers for Hepatocellular Carcinoma.
    Hammad G; Magdy M; Aboushousha T; Abdelraouf A; Mamdouh S
    Asian Pac J Cancer Prev; 2024 Jun; 25(6):2123-2131. PubMed ID: 38918675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoplasmic Expression of the EGFL6 Protein Is an Independent Prognostic Factor for Shortened Patient Survival in Human Hepatocellular Carcinoma.
    Hsu HT; Lin YM; Hsing MT; Yeh KT; Lu JW; Yang SF
    In Vivo; 2024; 38(5):2455-2463. PubMed ID: 39187367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas.
    Yu B; Yang X; Xu Y; Yao G; Shu H; Lin B; Hood L; Wang H; Yang S; Gu J; Fan J; Qin W
    J Hepatol; 2009 May; 50(5):948-57. PubMed ID: 19303159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression patterns of P-element Induced Wimpy Testis (PIWI) transcripts are potential candidate markers for Hepatocellular Carcinoma.
    Hammad G; Mamdouh S; Seoudi DM; Seleem MI; Safwat G; Mohamed RH
    Cancer Biomark; 2024; 39(2):95-111. PubMed ID: 38043006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma.
    He C; Xu J; Zhang J; Xie D; Ye H; Xiao Z; Cai M; Xu K; Zeng Y; Li H; Wang J
    Hum Pathol; 2012 Sep; 43(9):1425-35. PubMed ID: 22406368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoplasmic and/or nuclear expression of β-catenin correlate with poor prognosis and unfavorable clinicopathological factors in hepatocellular carcinoma: a meta-analysis.
    Chen J; Liu J; Jin R; Shen J; Liang Y; Ma R; Lin H; Liang X; Yu H; Cai X
    PLoS One; 2014; 9(11):e111885. PubMed ID: 25401330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma.
    Lyu Z; Ma M; Xu Y; Wang X; Zhu Y; Ren W; Li T
    Int J Clin Oncol; 2020 Jul; 25(7):1334-1345. PubMed ID: 32347431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
    Ji F; Fu SJ; Shen SL; Zhang LJ; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
    BMC Cancer; 2015 Mar; 15():116. PubMed ID: 25880619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of metallothionein-1 and metallothionein-2 as a prognostic marker in hepatocellular carcinoma.
    Park Y; Yu E
    J Gastroenterol Hepatol; 2013 Sep; 28(9):1565-72. PubMed ID: 23662831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low levels of glycoprotein 96 indicate a worse prognosis in early-stage hepatocellular carcinoma patients after hepatectomy.
    Ji F; Zhang Y; Zhu ZB; Guo Y; Shen SL; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
    Hum Pathol; 2019 Apr; 86():193-202. PubMed ID: 30529751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis.
    Jin B; Gong Z; Yang N; Huang Z; Zeng S; Chen H; Hu S; Pan G
    Tumour Biol; 2016 May; 37(5):5911-7. PubMed ID: 26592251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of Anxa2 and Stat3 promote progression of hepatocellular carcinoma and predict poor prognosis.
    Tang L; Liu JX; Zhang ZJ; Xu CZ; Zhang XN; Huang WR; Zhou DH; Wang RR; Chen XD; Xiao MB; Qu LS; Lu CH
    Pathol Res Pract; 2019 Jun; 215(6):152386. PubMed ID: 30935762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation Between Low Cytoplasmic Expression of XBP1 and the Likelihood of Surviving Hepatocellular Carcinoma.
    Hsu HT; Lin YM; Hsing MT; Yeh KT; Lu JW; Yang SF
    In Vivo; 2024; 38(3):1316-1324. PubMed ID: 38688649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased Expression of EHD2 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular Carcinoma.
    Liu J; Ni W; Qu L; Cui X; Lin Z; Liu Q; Zhou H; Ni R
    Dig Dis Sci; 2016 Sep; 61(9):2554-67. PubMed ID: 27221498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis.
    Zhang JY; Xu D; Liu ZZ; Li Y; Wang LJ; Xing BC
    Chin Med J (Engl); 2017 Feb; 130(4):470-476. PubMed ID: 28218222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined phosphatase and tensin homolog (PTEN) loss and fatty acid synthase (FAS) overexpression worsens the prognosis of Chinese patients with hepatocellular carcinoma.
    Zhu X; Qin X; Fei M; Hou W; Greshock J; Bachman KE; Wooster R; Kang J; Qin CY
    Int J Mol Sci; 2012; 13(8):9980-9991. PubMed ID: 22949843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.